Cargando…
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539163/ https://www.ncbi.nlm.nih.gov/pubmed/37634011 http://dx.doi.org/10.1038/s41375-023-02008-6 |
| _version_ | 1785113438039572480 |
|---|---|
| author | Gisslinger, Heinz Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Kiladjian, Jean-Jacques |
| author_facet | Gisslinger, Heinz Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Kiladjian, Jean-Jacques |
| author_sort | Gisslinger, Heinz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10539163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105391632023-09-30 Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment Gisslinger, Heinz Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Kiladjian, Jean-Jacques Leukemia Letter Nature Publishing Group UK 2023-08-26 2023 /pmc/articles/PMC10539163/ /pubmed/37634011 http://dx.doi.org/10.1038/s41375-023-02008-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Gisslinger, Heinz Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Kiladjian, Jean-Jacques Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title | Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title_full | Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title_fullStr | Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title_full_unstemmed | Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title_short | Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| title_sort | event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539163/ https://www.ncbi.nlm.nih.gov/pubmed/37634011 http://dx.doi.org/10.1038/s41375-023-02008-6 |
| work_keys_str_mv | AT gisslingerheinz eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT kladechristoph eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT georgievpencho eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT krochmalczykdorota eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT gerchevakyuchukovaliana eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT egyedmiklos eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT dulicekpetr eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT illesarpad eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT pylypenkohalyna eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT sivchevalylia eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT mayerjiri eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT yablokovavera eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT krejcykurt eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT empsonvictoria eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT hasselbalchhansc eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT kralovicsrobert eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT kiladjianjeanjacques eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment AT eventfreesurvivalinpatientswithpolycythemiaveratreatedwithropeginterferonalfa2bversusbestavailabletreatment |